Second doses: the covid vaccines which are applied this week | Quotes for AstraZeneca, Sputnik V and Sinopharm

Argentina advances this week in the application of the second doses of Oxford / AstraZeneca, Sinopharm and also Sputnik V, corn at the same time, adolescent vaccination begins to be completed. The Province of Buenos Aires sent nothing less than two million posts and the Ministry of Health of CABA summoned more than 30,000 people per day, in all cases apply second doses. The difference between the two health policies is that In the Buenos Aires neighborhood, they are still looking for unvaccinated people: no less than a million doses have been applied as of August 1, in stations, in collective vaccinations which go from house to house and also by adding spontaneous who attend without a shift. During the current week, the first Pfizer vaccines are expected to arrive, which Minister Carla Vizzotti said will begin to be used in adolescents without previous illnesses.

The vaccination sequence planned for the next few days is as follows:

• The priority is the second doses of Oxford / AstraZeneca, since this vaccine had delays. The doses arrived last week on an AirCanada flight, but they only started being applied this Sunday and throughout the week. The active part was produced in Argentina but ultimately the finishing was done in Albuquerque, USA. The Liomont Laboratory in Mexico has successfully passed quality controls and its production supplies the rest of Latin American countries, always with the active element produced in mAbxience, from Garin. In the Province of Buenos Aires, citations and in CABA it will be used on Monday, Tuesday and Wednesday exclusively for the second doses of this vaccine. At this time, Oxford / AstraZeneca is not used as a second component of Sputnik.
• These days, but especially from Thursday, the Sinopharm vaccination will be completed, of course to those who received the first dose of the same vaccine.
• Also in the first days of the week, second doses of Sputnik V will be applied. The approval of a batch of 608,000 doses in Moscow is imminent, which would allow a strong advance in vaccination. In fact, Richmond has completed four million doses, but quality checks are slow. Yet they are already delivering and applying doses.
• Both in the province of Buenos Aires and in CABA began to summon adolescents, with previous illnesses, who received the first dose of Moderna. The appointment is close to the month of the first vaccination.
• Ultimately, 260,000 doses of Pfizer are expected to arrive in the next few days. There is an agreement that they apply to adolescents without previous illnesses. Most of the 20 million doses purchased will arrive in October, November and December, but with this first kick-off, the vaccination of young people between 12 and 17 years old will be launched on a more massive scale.

The main objective is to continue to close the gap with the arrival of the Delta variant, on the one hand with restrictions, but on the other hand with vaccination. In Brazil the entry seems difficult to stop. In Rio de Janeiro, it already affects 93% of those infected and this suggests – as Conicet immunologist Jorge Geffner has pointed out – that it will also end up being the predominant variant in Argentina. For the moment, it is not like that at all: the cases are counted by the tens, not yet by the thousands.

In the Province of Buenos Aires, although 11 million doses have already been applied 1, the strategy of continuing to find unvaccinated people is the main, said Minister Nicolás Kreplak. The total of those over 18 in the Buenos Aires district is 12,500,000 people, that is, 88 percent of adults are vaccinated with at least one dose. But even so, others are still wanted for the vaccine. Kreplak said he was very satisfied with what was achieved in August: more than a million new vaccines. The main thing is that everyone has initial protection: the second dose strengthens, but the first is decisive. The province ruled by Axel Kicillof has exceeded six million doses 2, or more than 70 percent of the over 50 population at risk. With the two million citations, it will reach about 80% of that band, although these vaccines also complement the vaccination of health, education and security forces personnel.